News blog
IS Pharma
- BY: Andrew Hore |
- POSTED: 27/07/2010 |
- COMMENTS: Add yours
Specialist pharma products supplier IS Pharma says that trading is in line with expectations in the first three months of this financial year.
Sales of Variquel, a treatment for uncontrolled bleeding from oesophageal varices, continue to grow. The first launch of oral pain treatment Episil was in the UK earlier in July. It will be launched in other European countries in the next 18 months.
The company has also recognised the remaining £700,000 of payments for the sale of Volplex and Isoplex
At 62.5p a share, up 2.75p, IS Pharma is valued at £19.2m.
© 2007 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- 2.4mNumber of messages posted on SocialGo networks
- $38mCost savings generated by ideas from WalMart staff over a two month period
- 19.4m
Number of people passing through Johannesburg Airport in 2007
- News Blog
- All micro news
Synchronica
Mobile messaging technology provider Synchronica, which is the subject of a contested, all-share bid from rival Myriad AG, has signed a letter of intent with TSX Venture Exchange-quoted Intertainment Media.
DCD Media
AIM-quoted Timeweave has bought convertible loan notes in DCD Media that can convert into a 29.9% stake in the TV programmes producer.
James Cropper
Paper and speciality fibres manufacturer James Cropper is investing $3m in a new manufacturing facility in New York State.
TEG Group
Peter Gyllenhammar has taken his stake in TEG Group to 3.2% following the purchase of 500,000 shares.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|